Bicycle Therapeutics Ltd (BCYC) stock news · rev $72.6M
Bicycle Therapeutics Ltd (BCYC) is a biotechnology company listed on US.
This BCYC news page leads with what Bicycle Therapeutics Ltd filed — not a scraped headline mill.
No cached 8-K sentence for BCYC yet. We will not pad this page with generic market recap.
Latest reported BCYC revenue for 2025-12-31 was $72.6M. Net income was -$219.0M. Revenue was up 105.8% from 2024-12-31 to 2025-12-31. BCYC currently screens at market cap $554.0M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the BCYC stock page; for the tape open the quote page.
BCYC stock news FAQ
What are BCYC's latest revenue and net income?
Latest cached Bicycle Therapeutics Ltd (BCYC) revenue for Dec 31, 2025 was $72.6M. Net income was -$219.0M. Statements: https://lician.com/financials/bcyc
How did BCYC revenue change from the prior cached period?
Cached Bicycle Therapeutics Ltd (BCYC) revenue was up 105.8% from $35.3M (Dec 31, 2024) to $72.6M (Dec 31, 2025). Statements: https://lician.com/financials/bcyc
What is BCYC's market cap?
Bicycle Therapeutics Ltd (BCYC) market cap is $554.0M on the latest cached fundamentals snapshot.
What kind of company is BCYC?
Bicycle Therapeutics Ltd (BCYC) is a biotechnology company listed on US.
Where is BCYC stock news listed?
Cached stock news for Bicycle Therapeutics Ltd (BCYC) is listed at https://lician.com/news/bcyc. Filings: https://lician.com/sec/bcyc
Not investment advice.